Results 201 to 210 of about 114,607 (256)

A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients

open access: yesInternational Journal of Cancer, Volume 159, Issue 7, Page 1829-1843, 1 October 2026.
Long non‐coding RNAs (lncRNAs) signatures are promising cancer biomarkers, since their dysregulation in tumors is reflected in body fluids. In this study, next‐generation sequencing, bioinformatics, and gene expression data were combined to investigate an lncRNA signature linked specifically to the cancer‐promoting YAP in several cancer types ...
Fabian Rose   +24 more
wiley   +1 more source

The Natural History of Residual and Recurrent Disease in Advanced Juvenile Nasopharyngeal Angiofibroma: A Systematic Review

open access: yesThe Laryngoscope, Volume 136, Issue 10, Page 4130-4138, October 2026.
Residual and recurrent disease in advanced juvenile nasopharyngeal angiofibromas (JNAs) demonstrate spontaneous involution, reduction in size, or long‐term stability following initial treatment in 95% of patients. In this systematic review of 131 patients with advanced JNA, only 2% of patients demonstrated disease progression during surveillance, but ...
Shivani Angelique Kumar   +2 more
wiley   +1 more source

Eustachian Tube Opening in Children With and Without Cleft Palate and Association With Otitis Media

open access: yesThe Laryngoscope, Volume 136, Issue 10, Page 4542-4551, October 2026.
Using transnasal endoscopy in 50 children, structural abnormalities of the torus tubarius—particularly the posterior lip—were significantly more common in children with cleft palate than in those without (52% vs. 20%). Adenoid size, dynamic Eustachian tube opening visibility, and the Eustachian Tube Inflammation Scale correlated with middle ear status ...
Kawin Atipas   +4 more
wiley   +1 more source

The Sleeping Giant: Metabolism and Autophagy in the Generation and Survival of Dormant Polyploid Giant Cancer Cells

open access: yesMedComm, Volume 7, Issue 10, October 2026.
Polyploid giant cancer cells (PGCCs) arise in response to stress and play a critical role in therapy resistance and tumor dormancy. These cells can evade conventional treatments and later contribute to cancer relapse by generating progeny through nonmitotic, amitotic mechanisms.
Silvia Guil‐Luna   +3 more
wiley   +1 more source

Cytoskeletal Dynamics in Cancer: From Pathogenesis to Treatment

open access: yesMedComm, Volume 7, Issue 10, October 2026.
This review systematically addresses the fundamental roles of the cytoskeleton (actin filaments, microtubules, and intermediate filaments) in cancer progression. We focus on how cytoskeletal dynamics regulate tumor proliferation, metastasis, and programmed cell death, while also modulating the immune microenvironment. Understanding these mechanisms may
Jie Chen   +9 more
wiley   +1 more source

Phase Angle as an Early Functional Biomarker of Cancer‐Related Fatigue in Pediatric Oncology: A Prospective Longitudinal Study

open access: yesPediatric Blood &Cancer, Volume 73, Issue 9, September 2026.
ABSTRACT Background Pediatric cancer remains a leading cause of morbidity and mortality worldwide, particularly in low‐and middle‐income countries. Cancer treatment may impair nutritional status, alter body composition, and exacerbate cancer‐related fatigue (CRF).
Luís Carlos Lopes‐Junior   +11 more
wiley   +1 more source

How bone mis‐segmentation affects MRI‐based sCT dosimetry in head and neck radiotherapy: A CT‐referenced study

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 9, September 2026.
Abstract Background Magnetic resonance imaging (MRI) is commonly used for head‐and‐neck (H&N) delineation in radiotherapy (RT) owing to the lack of contrast in computed tomography (CT) images. MRI‐based dosimetry is not yet fully developed for the H&N area due to the inter‐patient variability and the difficulty of accurately quantifying cortical bone ...
Laura Sayaque   +7 more
wiley   +1 more source

A Monte Carlo based dose verification tool for an HDR Ir‐192 brachytherapy source and its evaluation on extremity malignancies

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 9, September 2026.
Abstract Background TG‐43 formalism dose calculation for brachytherapy with the homogeneous water‐based assumption is widely used, which can lead to dose inaccuracy in treatment planning. Purpose Extremity malignancies are also treated with high‐dose‐rate (HDR) 192Ir interstitial brachytherapy, a treatment site that has not been specifically ...
Peixiong Li   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy